Allarity Therapeutics Inc... (ALLR)
NASDAQ: ALLR
· Real-Time Price · USD
0.95
-0.03 (-3.04%)
At close: Aug 15, 2025, 3:59 PM
0.99
3.97%
After-hours: Aug 15, 2025, 07:41 PM EDT
Allarity Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 112K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 1K | 2K | 9K | 18K | 18K | 20K | 4K | 31K | 42K | 23K | 16K | 14K | n/a | 56K |
Gross Profit | n/a | n/a | n/a | -1K | -2K | 103K | -18K | -18K | -20K | -4K | -31K | -42K | -23K | -16K | -14K | n/a | -56K |
Operating Income | -3.04M | -7.32M | -12.31M | -3.37M | -4.24M | -4.88M | -4.43M | -4.16M | -3.66M | -6.75M | -4.56M | -4.33M | -18.31M | -16.09M | -3.19M | -4.38M | -2.46M |
Interest Income | 222K | 219K | 261K | 53K | n/a | 3K | 12K | 3K | 4K | 11K | 14K | 5K | n/a | n/a | 28K | n/a | n/a |
Pretax Income | -2.73M | -7.45M | -11.97M | -1.63M | -3.85M | -1.64M | -5.55M | -2.38M | -3.35M | -3.14M | -5.03M | -4.65M | -4.31M | -19.47M | 1.27M | -5.37M | -3.05M |
Net Income | -2.73M | -7.45M | -12.15M | -1.63M | -3.84M | -1.72M | -5.55M | -2.38M | -3.14M | -2.84M | -5.04M | -4.66M | -3.08M | -20.66M | 1.67M | -5.4M | -3.08M |
Selling & General & Admin | 1.63M | 5.47M | 1.59M | 2.31M | 2.07M | 2.26M | 2.48M | 3.05M | 2.23M | 2.25M | 1.56M | 2.93M | 3.01M | 6.22M | 2.62M | 2.1M | 1.21M |
Research & Development | 1.4M | 1.85M | 1.02M | 1.06M | 2.17M | 2.61M | 1.95M | 1.1M | 1.43M | 941K | 3M | 1.4M | 1.29M | 8.87M | 1.57M | 2.28M | 1.25M |
Other Expenses | n/a | n/a | 9.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -201K |
Operating Expenses | 3.04M | 7.32M | 12.31M | 3.37M | 4.24M | 4.87M | 4.43M | 4.16M | 3.66M | 3.19M | 4.56M | 4.33M | 4.3M | 15.09M | 4.19M | 4.38M | 2.46M |
Interest Expense | 57K | 75K | 50K | 426K | 102K | 230K | 34K | 142K | 92K | 116K | 35K | 33K | 39K | 348K | 27K | 253K | 79K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 7.32M | 12.31M | 3.37M | 4.24M | 4.88M | 4.43M | 4.16M | 3.66M | 3.19M | 4.56M | 4.33M | 4.3M | 15.09M | 4.19M | 4.38M | 2.46M |
Income Tax Expense | n/a | n/a | -377K | n/a | -4K | 83K | -9K | n/a | -211K | -303K | 5K | 4K | -1.23M | 1.19M | -406K | 30K | 33K |
Shares Outstanding (Basic) | 1.11M | 1.58M | 1.5M | 499.3K | 5.84K | 9.81K | 4.12K | 620.69 | 31.59 | 16.09 | 11.75 | 10.73 | 9.87 | 9.64 | 9.23 | 3.89 | 3.89 |
Shares Outstanding (Diluted) | 1.11M | 1.58M | 1.58M | 499.3K | 5.84K | 9.81K | 4.12K | 620.69 | 31.59 | 16.09 | 11.75 | 10.73 | 9.87 | 9.64 | 9.23 | 3.89 | 3.89 |
EPS (Basic) | -0.25 | -4.73 | -8.09 | -3.4 | -696.83 | -175.51 | -1.35K | -15.77K | -106.24K | -192.76K | -568.69K | -603.67K | -471.47K | -1.74M | -146.37K | -15.72K | -205.36K |
EPS (Diluted) | -0.25 | -4.73 | -7.71 | -3.4 | -696.83 | -175.51 | -1.35K | -15.77K | -106.24K | -192.76K | -568.69K | -603.67K | -471.47K | -1.74M | -146.37K | -15.72K | -205.36K |
EBITDA | -3.04M | -7.38M | -12.31M | -1.2M | -3.74M | -1.4M | -4.43M | -2.22M | -3.23M | -3.02M | -4.97M | -5.02M | -4.25M | -16.5M | -1.27M | -5.04M | -2.83M |
EBIT | n/a | -7.38M | -11.92M | -1.2M | -3.75M | -1.41M | -4.41M | -2.24M | -3.26M | -3.02M | -5M | -5.07M | -4.27M | -19.45M | -1.29M | -5.2M | -2.97M |
Depreciation & Amortization | n/a | 1K | n/a | 1K | 2K | 9K | 18K | 18K | 20K | 4K | 31K | 42K | 23K | 16K | 14K | -3K | 56K |